A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy

被引:4
|
作者
Kim, Sung Han [1 ]
Park, Boram [2 ]
Hwang, Eu Chang [3 ]
Hong, Sung-Hoo [4 ]
Jeong, Chang Wook [5 ]
Kwak, Cheol [5 ]
Byun, Seok Soo [6 ]
Chung, Jinsoo [1 ]
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Urol Canc Ctr, Dept Urol, Goyang, South Korea
[2] Samsung Med Ctr, Res Inst Future Med, Stat & Data Ctr, Seoul, South Korea
[3] Chonnam Natl Univ, Med Sch, Dept Urol, Gwangju, South Korea
[4] Seoul St Marys Hosp, Dept Urol, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med & Hosp, Dept Urol, Seoul, South Korea
[6] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
prognosis; nephrectomy; metastasis; renal cell carcinoma; recurrence; SURGICAL-TREATMENT; SURGERY; RECURRENCE; SURVIVAL; INVASION; IMPACT;
D O I
10.3389/fonc.2021.653002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to compare the cancer-specific survival (CSS) and overall survival (OS) of nephrectomized patients with non-metastatic renal cell carcinoma (nmRCC) and local recurrence without distant metastasis (LR group), those with metastasis without local recurrence (MET group), and those with both local recurrence and metastasis (BOTH group). This retrospective multicenter study included 464 curatively nephrectomized patients with nmRCC and disease recurrence between 2000 and 2012; the follow-up period was until 2017. After adjusting for significant clinicopathological factors using Cox proportional hazard models, CSS and OS were compared between the MET (n = 50, 10.7%), BOTH (n = 95, 20.5%), and LR (n = 319, 68.8%) groups. The CSS and OS rates were 34.7 and 6.5% after a median follow-up of 43.9 months, respectively. After adjusting for significant prognostic factors of OS and CSS, the MET group had hazard ratios (HRs) of 0.51 and 0.57 for OS and CSS (p = 0.039 and 0.103), respectively, whereas the BOTH group had HRs of 0.51 and 0.60 for OS and CSS (p < 0.05), respectively; LR was taken as a reference. The 2-year OS and CSS rates from the date of nephrectomy and disease recurrence were 86.9% and 88.9% and 63.5% and 67.8%, respectively, for the LR group; 89.5% and 89.5% and 48.06% and 52.43%, respectively, for the MET group; and 96.8% and 96.8% and 86.6% and 82.6%, respectively, for the BOTH group. Only the LR and BOTH groups had significant differences in the 2-year OS and CSS rates (p < 0.05). In conclusion, our study showed that the LR group had worse survival prognoses than any other group in nephrectomized patients with nmRCC.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
    Kim, Sung Han
    Park, Boram
    Hwang, Eu Chang
    Hong, Sung-Hoo
    Jeong, Chang Wook
    Kwak, Cheol
    Byun, Seok Soo
    Chung, Jinsoo
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [2] Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma
    Kassouf, Wassim
    Siemens, Robert
    Morash, Christopher
    Lacombe, Louis
    Jewett, Michael
    Goldenberg, Larry
    Chin, Joseph
    Chetner, Michael
    Wood, Christopher G.
    Tanguay, Simon
    Aprikian, Armen G.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (01): : 73 - 76
  • [3] Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up
    Barth, Dominik A.
    Sareban, Nazanin
    Lindner, Andrea K.
    Daller, Louisa A. J.
    Matzhold, Eva Maria
    Hutterer, Georg
    Smolle, Maria
    Mischinger, Johannes
    Riedl, Jakob M.
    Seles, Maximilian
    Mannweiler, Sebastian
    Bauernhofer, Thomas
    Pummer, Karl
    Pichler, Renate
    Zigeuner, Richard
    Schlenke, Peter
    Pichler, Martin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 736.e9 - 736.e16
  • [4] Positive margins after partial nephrectomy in renal cell carcinoma: Ontological outcomes of conservative management after long-term follow-up
    Fernandez-Concha Schwalb, J. J.
    Perez Reggeti, J., I
    Lopez Costea, M. A.
    Bonet Punti, X.
    Ramos Reina, H.
    Vigues Julia, F.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (08): : 414 - 418
  • [5] Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma
    Williamson, Timothy J.
    Pearson, John R.
    Ischia, Joseph
    Bolton, Damien M.
    Lawrentschuk, Nathan
    BJU INTERNATIONAL, 2016, 117 (04) : 555 - 562
  • [6] The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol
    Antonelli, Alessandro
    Cozzoli, Alberto
    Zani, Danilo
    Zanotelli, Tiziano
    Nicolai, Maria
    Cunico, Sergio Cosciani
    Simeone, Claudio
    BJU INTERNATIONAL, 2007, 99 (02) : 296 - 300
  • [7] Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy
    Ljungberg, B
    Alamdari, FI
    Rasmuson, T
    Roos, G
    BJU INTERNATIONAL, 1999, 84 (04) : 405 - 411
  • [8] Prognostic value of microscopic venous invasion in renal cell carcinoma: Long-term follow-up
    Lang, H
    Lindner, V
    Letourneux, H
    Martin, M
    Saussine, C
    Jacqmin, D
    EUROPEAN UROLOGY, 2004, 46 (03) : 331 - 335
  • [9] Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis
    Dabestani, Saeed
    Beisland, Christian
    Stewart, Grant D.
    Bensalah, Karim
    Gudmundsson, Eirikur
    Lam, Thomas B.
    Gietzmann, William
    Zakikhani, Paimaun
    Marconi, Lorenzo
    Fernandez-Pello, Sergio
    Monagas, Serenella
    Williams, Samuel P.
    Torbrand, Christian
    Powles, Thomas
    Van Werkhoven, Erik
    Meijer, Richard
    Volpe, Alessandro
    Staehler, Michael
    Ljungberg, Borje
    Bex, Axel
    EUROPEAN UROLOGY FOCUS, 2019, 5 (05): : 857 - 866
  • [10] Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy
    Zubac, Dragomir P.
    Bostad, Leif
    Gestblom, Charlotta
    Kihl, Bjorn
    Seidal, Tomas
    Wentzel-Larsen, Tore
    Bakke, August M.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (03): : 191 - 197